DIVA Laboratories, Ltd. (4153.TWO)
TWD 38.75
(-1.77%)
TWD 38.75
(-1.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 252.91 Million | 73.18 Million | -11.39 Million | -16.64 Million | 52.66 Million |
| Net Income | 73.61 Million | 67.64 Million | 28.46 Million | 27.55 Million | 65.45 Million |
| Depreciation & Amortization | 9.06 Million | 10.09 Million | 13.71 Million | 19.03 Million | 19.46 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 147.04 Million | -61.3 Million | -38.22 Million | -72.9 Million | -6.2 Million |
| Other non-cash items | 23.18 Million | -560 Thousand | -423 Thousand | -3.58 Million | -6.85 Million |
| Investing Cash Flow | -3.2 Million | -5.04 Million | 2.61 Million | -5.29 Million | -51.91 Million |
| Investments in PPE | -7.48 Million | -11.41 Million | -12.85 Million | -21.76 Million | -12.79 Million |
| Acquisitions | - | 5.41 Million | - | - | - |
| Investment purchases | -117 Thousand | -7.05 Million | -7.12 Million | -111.05 Million | -59.96 Million |
| Sales/Maturities of investments | 117 Thousand | 7.77 Million | 10.33 Million | 122.56 Million | 1.42 Million |
| Other Investing Activities | 4.28 Million | -464 Thousand | -252 Thousand | -115 Thousand | -118 Thousand |
| Financing Cash Flow | -59.12 Million | -22.03 Million | -15.49 Million | -160.72 Million | -106.72 Million |
| Debt repayment | -130 Thousand | -128 Thousand | - | - | - |
| Dividends payments | -58.66 Million | -21.7 Million | -15.25 Million | - | -106.6 Million |
| Common Stock Repurchased | - | - | - | -160.53 Million | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -329 Thousand | -329 Thousand | - | - | - |
| Accounts receivables | 70.14 Million | -96.5 Million | - | - | - |
| Accounts payables | -24.08 Million | -18.72 Million | - | - | - |
| Inventory | 89.17 Million | 28.01 Million | -103.46 Million | -71.41 Million | -4.24 Million |
| Other working capital | -12.27 Million | 7.19 Million | - | - | - |
| Cash at beginning of period | 346.36 Million | 299.27 Million | 323.75 Million | 506.65 Million | 611.37 Million |
| Cash at end of period | 536.92 Million | 346.36 Million | 299.27 Million | 323.75 Million | 506.65 Million |
| Capital Expenditure | -7.48 Million | -11.41 Million | -12.85 Million | -21.76 Million | -12.79 Million |
| Effect of forex changes on cash | -23 Thousand | 986 Thousand | -219 Thousand | -240 Thousand | 1.26 Million |
| Net cash flow / Change in cash | 190.55 Million | 47.09 Million | -24.48 Million | -182.89 Million | -104.71 Million |
| Free Cash Flow | 245.42 Million | 61.77 Million | -24.24 Million | -38.4 Million | 39.86 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.87 Million | 32.27 Million | 31.9 Million | 21.03 Million | 25.21 Million | 8.03 Million |
| Depreciation & Amortization | 2.64 Million | 2.79 Million | 2.82 Million | 2.34 Million | 2.39 Million | 2.21 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.59 Million | -12.76 Million | 13.85 Million | 54.38 Million | -27.49 Million | 119.99 Million |
| Other non-cash items | -14.72 Million | -1.34 Million | -1.12 Million | 251 Thousand | -1.1 Million | -1.11 Million |
| Investing Cash Flow | 561 Thousand | 1.86 Million | 1.15 Million | 70 Thousand | 709 Thousand | -2.65 Million |
| Investments in PPE | -593 Thousand | - | -100 Thousand | -1.36 Million | -511 Thousand | -3.8 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | 1000.00 | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 691 Thousand | 114 Thousand | 70 Thousand | 1.43 Million | -118 Thousand | 109 Thousand |
| Financing Cash Flow | -74 Million | -742 Thousand | -665 Thousand | -34 Thousand | -58.81 Million | -74 Thousand |
| Debt repayment | - | -631 Thousand | - | -33 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -74 Million | -111 Thousand | - | -1000.00 | - | - |
| Accounts receivables | 22.26 Million | -19.86 Million | - | 49.41 Million | - | - |
| Accounts payables | - | 4.73 Million | - | -2.89 Million | - | - |
| Inventory | 3.52 Million | -532 Thousand | 18.27 Million | 12.46 Million | 8.45 Million | 25.88 Million |
| Other working capital | -21.19 Million | 6.78 Million | - | -7.49 Million | - | - |
| Cash at beginning of period | 607.65 Million | 585.34 Million | 536.92 Million | 459.62 Million | 515.98 Million | 366.43 Million |
| Cash at end of period | 546.19 Million | 607.65 Million | 585.34 Million | 536.92 Million | 459.62 Million | 515.98 Million |
| Capital Expenditure | -593 Thousand | - | -100 Thousand | -1.36 Million | -511 Thousand | -3.8 Million |
| Effect of forex changes on cash | -408 Thousand | 315 Thousand | 705 Thousand | -755 Thousand | 590 Thousand | 242 Thousand |
| Net cash flow / Change in cash | -61.45 Million | 22.3 Million | 48.42 Million | 77.29 Million | -56.35 Million | 149.54 Million |
| Free Cash Flow | 11.79 Million | 20.86 Million | 47.12 Million | 76.65 Million | 651 Thousand | 148.22 Million |
HSTC
ASTRAL
AHCHY
RBL
GEOJITFSL
BRITANNIA